A defined xeno-free and feeder-free culture system for the derivation, expansion and direct differentiation of transgene-free patient-specific induced pluripotent stem cells

Biomaterials

Volumn 35, Issue 9, 2014, Pages 2816-2826

  Lu, Hong Fang ^a   Chai, Chou ^b   Lim, Tze Chiun ^a   Leong, Meng Fatt ^a   Lim, Jia Kai ^a   Gao, Shujun ^a   Lim, Kah Leong ^b,c   Wan, Andrew C A ^a  

^a INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c National Neuroscience Institute   (Singapore)

Author keywords

Direct differentiation; Expansion; IPSC; Laminin 521; Reprogramming; Xeno free culture

Indexed keywords

DIRECT DIFFERENTIATION; EXPANSION; IPSC; LAMININ 521; REPROGRAMMING; XENO-FREE CULTURE;

ADULT; ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; DOPAMINERGIC NEURONS; FEEDER CELLS; FIBROBLASTS; GENETIC VECTORS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LENTIVIRUS; MICE; MICE, SCID; NUCLEAR REPROGRAMMING; PARKINSON DISEASE; TRANSGENES;

EID: 84895003119     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.12.050     Document Type: Article

References (48)

1. Byrne J.A. Generation of isogenic pluripotent stem cells. Hum Mol Genet 2008, 17:R37-R41.
2. Byrne J. Nuclear reprogramming and the current challenges in advancing personalized pluripotent stem cell-based therapies. Gene Ther Reg 2013, 07. 1230002-1230011-1230002-24.
3. Grskovic M., Javaherian A., Strulovici B., Daley G.Q. Induced pluripotent stem cells-opportunities for disease modelling and drug discovery. Nat Rev Drug Discov 2011, 10:915-929.
4. Hanna J., Wernig M., Markoulaki S., Sun C.W., Meissner A., Cassady J.P., et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007, 318:1920-1923.
5. Carvajal-Vergara X., Sevilla A., D'Souza S.L., Ang Y.S., Schaniel C., Lee D.F., et al. Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 2010, 465:808-812.
6. Rais Y., Zviran A., Geula S., Gafni O., Chomsky E., Viukov S., et al. Deterministic direct reprogramming of somatic cells to pluripotency. Nature 2013, 502:65-70.
7. Hanna J.H., Saha K., Jaenisch R. Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell 2010, 143:508-525.
8. Ahrlund-Richter L., De Luca M., Marshak D.R., Munsie M., Veiga A., Rao M. Isolation and production of cells suitable for human therapy: challenges ahead. Cell Stem Cell 2009, 4:20-26.
9. Warren L., Ni Y., Wang J., Guo X. Feeder-free derivation of human induced pluripotent stem cells with messenger RNA. Sci Rep 2012, 2:657.
10. Macarthur C.C., Fontes A., Ravinder N., Kuninger D., Kaur J., Bailey M., et al. Generation of human-induced pluripotent stem cells by a nonintegrating RNA Sendai virus vector in feeder-free or xeno-free conditions. Stem Cells Int 2012, 2012:564612.
11. Awe J.P., Lee P.C., Ramathal C., Vega-Crespo A., Durruthy-Durruthy J., Cooper A., et al. Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status. Stem Cell Res Ther 2013, 4:87.
12. Sun N., Panetta N.J., Gupta D.M., Wilson K.D., Lee A., Jia F., et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci U S A 2009, 106:15720-15725.
13. Chen G., Gulbranson D.R., Hou Z., Bolin J.M., Ruotti V., Probasco M.D., et al. Chemically defined conditions for human iPSC derivation and culture. Nat Methods 2011, 8:424-429.
14. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
15. Ma T., Xie M., Laurent T., Ding S. Progress in the reprogramming of somatic cells. Circ Res 2013, 112:562-574.
16. Dimos J.T., Rodolfa K.T., Niakan K.K., Weisenthal L.M., Mitsumoto H., Chung W., et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008, 321:1218-1221.
17. Park I.H., Arora N., Huo H., Maherali N., Ahfeldt T., Shimamura A., et al. Disease-specific induced pluripotent stem cells. Cell 2008, 134:877-886.
18. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
19. Domogatskaya A., Rodin S., Boutaud A., Tryggvason K. Laminin-511 but not -332, -111, or -411 enables mouse embryonic stem cell self-renewal in vitro. Stem Cells 2008, 26:2800-2809.
20. Anokye-Danso F., Trivedi C.M., Juhr D., Gupta M., Cui Z., Tian Y., et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 2011, 8:376-388.
21. Yu J., Hu K., Smuga-Otto K., Tian S., Stewart R., Slukvin, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009, 324:797-801.
22. Kaji K., Norrby K., Paca A., Mileikovsky M., Mohseni P., Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009, 458:771-775.
23. Okita K., Nakagawa M., Hyenjong H., Ichisaka T., Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008, 322:949-953.
24. Stadtfeld M., Nagaya M., Utikal J., Weir G., Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 2008, 322:945-949.
25. Jia F., Wilson K.D., Sun N., Gupta D.M., Huang M., Li Z., et al. A nonviral minicircle vector for deriving human iPS cells. Nat Methods 2010, 7:197-199.
26. Lin T., Ambasudhan R., Yuan X., LI W., Hilcove S., Abujarour R., et al. A chemical platform for improved induction of human iPSCs. Nat Methods 2009, 6:805-808.
27. Zhang Z., Gao Y., Gordon A., Wang Z.Z., Qian Z., Wu W.S. Efficient generation of fully reprogrammed human iPS cells via polycistronic retroviral vector and a new cocktail of chemical compounds. PLoS One 2011, 6:e26592.
28. Lai M.I., Wendy-Yeo W.Y., Ramasamy R., Nordin N., Rosli R., Veerakumarasivam A., et al. Advancements in reprogramming strategies for the generation of induced pluripotent stem cells. J Assist Reprod Genet 2011, 28:291-301.
29. Sommer C.A., Mostoslavsky G. The evolving field of induced pluripotency: recent progress and future challenges. J Cell Physiol 2013, 228:267-275.
30. Chang C.W., Lai Y.S., Pawlik K.M., Liu K., Sun C.W., Li C., et al. Polycistronic lentiviral vector for "hit and run" reprogramming of adult skin fibroblasts to induced pluripotent stem cells. Stem Cells 2009, 27:1042-1049.
31. Cooper A.R., MacQueen H.A. Subunits of laminin are differentially synthesized in mouse eggs and early embryos. Dev Biol 1983, 96:467-471.
32. Aumailley M., Bruckner-Tuderman L., Carter W.G., Deutzmann R., Edgar D., Ekblom P., et al. A simplified laminin nomenclature. Matrix Biol 2005, 24:326-332.
33. Rodin S., Domogatskaya A., Strom S., Hansson E.M., Chien K.R., Inzunza J., et al. Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511. Nat. Biotechnol 2010, 28:611-615.
34. Miyazaki T., Futaki S., Suemori H., Taniguchi Y., Yamada M., Kawasaki M., et al. Laminin E8 fragments support efficient adhesion and expansion of dissociated human pluripotent stem cells. Nat Commun 2012, 3:1236.
35. Vuoristo S., Virtanen I., Takkunen M., Palgi J., Kikkawa Y., Rousselle P., et al. Laminin isoforms in human embryonic stem cells: synthesis, receptor usage and growth support. J Cell Mol Med 2009, 13:2622-2633.
36. Lu H.F., Narayanan K., Lim S.X., Gao S., Leong M.F., Wan A.C. A 3D microfibrous scaffold for long-term human pluripotent stem cell self-renewal under chemically defined conditions. Biomaterials 2012, 33:2419-2430.
37. Kriks S., Shim J.W., Piao J., Ganat Y.M., Wakeman D.R., Xie Z., et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 2011, 480:547-551.
38. Lu H.F., Lim S.X., Leong M.F., Narayanan K., Toh R.P., Gao S., et al. Efficient neuronal differentiation and maturation of human pluripotent stem cells encapsulated in 3D microfibrous scaffolds. Biomaterials 2012, 33:9179-9187.
39. Nakagawa M., Koyanagi M., Tanabe K., Takahashi K., Ichisaka T., Aoi T., et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008, 26:101-106.
40. Klim J.R., Li L., Wrighton P.J., Piekarczyk M.S., Kiessling L.L. A defined glycosaminoglycan-binding substratum for human pluripotent stem cells. Nat Methods 2010, 7:989-994.
41. Ludwig T.E., Levenstein M.E., Jones J.M., Berggren W.T., Mitchen E.R., Frane J.L., et al. Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol 2006, 24:185-187.
42. Mei Y., Saha K., Bogatyrev S.R., Yang J., Hook A.L., Kalcioglu Z.I., et al. Combinatorial development of biomaterials for clonal growth of human pluripotent stem cells. Nat Mater 2010, 9:768-778.
43. Melkoumian Z., Weber J.L., Weber D.M., Fadeev A.G., Zhou Y., Dolley-Sonneville P., et al. Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells. Nat Biotechnol 2010, 28:606-610.
44. Tsutsui H., Valamehr B., Hindoyan A., Qiao R., Ding X., Guo S., et al. An optimized small molecule inhibitor cocktail supports long-term maintenance of human embryonic stem cells. Nat Commun 2011, 2:167.
45. Villa-Diaz L.G., Nandivada H., Ding J., Nogueira-de-Souza N.C., Krebsbach P.H., O'Shea K.S., et al. Synthetic polymer coatings for long-term growth of human embryonic stem cells. Nat Biotechnol 2010, 28:581-583.
46. Braam S.R., Zeinstra L., Litjens S., Ward-van Oostwaard D., van den B.S., van Laake L., et al. Recombinant vitronectin is a functionally defined substrate that supports human embryonic stem cell self-renewal via alphavbeta5 integrin. Stem Cells 2008, 26:2257-2265.
47. Gaudet F., Hodgson J.G., Eden A., Jackson-Grusby L., Dausman J., Gray J.W., et al. Induction of tumors in mice by genomic hypomethylation. Science 2003, 300:489-492.
48. Somers A., Jean J.C., Sommer C.A., Omari A., Ford C.C., Mills J.A., et al. Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells 2010, 28:1728-1740.